PRIMARY LIVER-CANCER IN GENETIC HEMOCHROMATOSIS - A CLINICAL, PATHOLOGICAL, AND PATHOGENETIC STUDY OF 54 CASES

被引:149
作者
DEUGNIER, YM
GUYADER, D
CRANTOCK, L
LOPEZ, JM
TURLIN, B
YAOUANQ, J
JOUANOLLE, H
CAMPION, JP
LAUNOIS, B
HALLIDAY, JW
POWELL, LW
BRISSOT, P
机构
[1] CHRU PONTCHAILLOU,INSERM,U49,F-35033 RENNES,FRANCE
[2] ROYAL BRISBANE HOSP,DEPT MED,BRISBANE,QLD 4029,AUSTRALIA
[3] QUEENSLAND INST MED RES,BRISBANE,AUSTRALIA
[4] FAC MED PORTO,ANAT PATHOL LAB,OPORTO,PORTUGAL
[5] CTR HOSP REG & UNIV PONTCHAILLOU,DEPT SANTE PUBL,RENNES,FRANCE
[6] CTR HOSP REG & UNIV PONTCHAILLOU,ANAT PATHOL LAB B,RENNES,FRANCE
[7] CTR HOSP REG & UNIV PONTCHAILLOU,CHIRURG CLIN B,RENNES,FRANCE
关键词
D O I
10.1016/0016-5085(93)90856-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although liver cancer arises frequently in the course of genetic hemochromatosis (GH), it has not been previously studied in a large series of patients with well-defined GH. Methods: The bioclinical and pathological data from 1 cholangiocarcinoma and 53 hepatocellular carcinomas (HCCs) complicating GH in 32 untreated and 22 de-ironed patients are reported. Results: This study (1) adds three new well-documented cases of HCC in noncirrhotic but only fibrotic hemochromatotic liver, (2) shows the high prevalence (83%) of proliferative and often dysplastic (70%) iron-free foci in the nontumorous liver of untreated patients, and (3) emphasizes the significant increase of cirrhosis (81% vs. 28%) and of associated noniron-related risk factors, mainly chronic alcoholism (48% vs. 25%) and tobacco smoking (50% vs. 18%) in patients with HCC compared with matched hemochromatotic patients without HCC. Conclusions: These data (1) suggest that iron-free foci may be markers of an early stage of HCC in GH and (2) supply the basis for defining a cost-effective policy for the screening of HCC in GH patients. © 1993.
引用
收藏
页码:228 / 234
页数:7
相关论文
共 41 条
[1]   LIVER-CELL DYSPLASIA - PREMALIGNANT CONDITION [J].
ANTHONY, PP ;
VOGEL, CL ;
BARKER, LF .
JOURNAL OF CLINICAL PATHOLOGY, 1973, 26 (03) :217-223
[2]  
BARRY M, 1971, LANCET, V1, P100
[3]   HLA TYPING IN IDIOPATHIC HEMOCHROMATOSIS - DISTINCTION BETWEEN HOMOZYGOTES AND HETEROZYGOTES WITH BIOCHEMICAL EXPRESSION [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1981, 1 (02) :120-126
[4]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[5]  
Berk JE, 1941, AM J MED SCI, V202, P708
[6]   PRIMARY HEPATOCELLULAR-CARCINOMA IN IDIOPATHIC HEMOCHROMATOSIS AFTER REVERSAL OF CIRRHOSIS [J].
BLUMBERG, RS ;
CHOPRA, S ;
IBRAHIM, R ;
CRAWFORD, J ;
FARRAYE, FA ;
ZELDIS, JB ;
BERMAN, MD .
GASTROENTEROLOGY, 1988, 95 (05) :1399-1402
[7]  
BOMFORD A, 1976, Q J MED, V45, P611
[8]  
BRADBEAR RA, 1985, J NATL CANCER I, V75, P81
[9]  
BRADBEAR RA, 1987, NEOPLASMS LIVER, P191
[10]  
BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557